Atrial fibrillation
Conditions
Interventions
Experimental Group:Standard Western medical treatment + Lian-xia-ling-zhu Granules
Control Group:Standard Western medical treatment + Lianxia Lingzhu Granules placebo
Sponsors
Beijing Anzhen Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) 18 years = age = 75 years, gender; (2) With a clear history of atrial fibrillation, having received only one radiofrequency ablation, and successfully converted to sinus rhythm within 1 week of treatment; (3) Consistent with the syndrome of internal disturbance by phlegm-heat in traditional Chinese medicine; (4) Not currently considering undergoing another cardiac radiofrequency ablation; (5) Voluntarily participating in this trial and signing the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Structural heart disease, acute coronary syndrome; (2) Severe liver and kidney dysfunction, malignant tumors, hematological diseases, acute infectious diseases, etc.; (3) Expected survival period <12 months; (4) Participation in or enrollment in other clinical studies within the past month prior to enrollment; (5) Severe cognitive impairment or inability to communicate for other reasons; (6) Women who are planning pregnancy, pregnant, or breastfeeding; (7) Allergy to Lianxiaolingzhú granules or related traditional Chinese medicine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence rate of atrial fibrillation one year after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| The frequency and duration of atrial fibrillation episodes.;Atrial Fibrillation Patients' Quality of Life Questionnaire (AFEQT);Adverse cardio-cerebrovascular event incidence rate;Atrial Fibrillation Burden, Proportion of Cardioversion;Echocardiogram (left atrial anteroposterior diameter, left atrial volume index, and left ventricular ejection fraction);Traditional Chinese Medicine Syndrome Scoring Scale; | — |
Countries
China
Contacts
Public ContactCaihua Sang
Beijing Anzhen Hospital, Capital Medical University
Outcome results
None listed